Danaher Reports Second Quarter 2026 Results — TradingView News

WASHINGTON, July 21, 2026 /PRNewswire/ — Danaher Corporation (DHR) immediately introduced outcomes for the second quarter 2026. All outcomes on this launch replicate solely persevering with operations and period-to-period comparisons are year-over-year until in any other case famous.

Key Second Quarter 2026 Results

• Net earnings had been $870 million, or $1.23 per diluted widespread share, up 60% year-over-year.
• Non-GAAP adjusted diluted web earnings per widespread share grew 8.0% to $1.94.
• Revenues elevated 5.5% year-over-year to $6.3 billion.
• Non-GAAP core income elevated 3.0% year-over-year and non-GAAP core income excluding respiratory testing income elevated 4.5% year-over-year.
• Operating money move was $1.5 billion and non-GAAP free money move was $1.3 billion.
• Strong Q2 earnings efficiency and earlier-than-anticipated completion of Masimo acquisition enabling elevated full yr 2026 adjusted diluted web earnings per widespread share steerage.

Rainer M. Blair, President and Chief Executive Officer, said, “We delivered a better than expected second quarter, with core growth improving versus the first quarter and disciplined execution driving high-single-digits adjusted EPS growth. Our Life Sciences businesses delivered their strongest quarter in several years and while customer project timing impacted bioprocessing revenue, underlying order trends remained strong and bioprocessing orders grew mid-teens in the quarter.”

Mr. Blair continued, “Looking ahead, continued end-market recovery and traction from our recent growth initiatives support our expectation to exit 2026 at a mid-single-digit core revenue growth rate. Longer term, Danaher’s leading portfolio, capital deployment optionality and talented team — all powered by the Danaher Business System — position us to accelerate the impact of science and technology, help customers move from discovery to delivery faster, and create sustainable long-term shareholder value.”

Third Quarter and Full Year 2026 Outlook

Danaher Corporation (the “Company”) doesn’t reconcile non-GAAP forecasted core gross sales development, adjusted working revenue margin and adjusted diluted web earnings per widespread share to their respective, comparable measure ready in accordance with U.S. typically accepted accounting rules (GAAP) as a result of (aside from estimated amortization of acquisition-related intangible belongings of $0.5 billion for the third quarter and $1.9 billion for the yr ending December 31, 2026 and the estimated affect of overseas foreign money on gross sales, which is estimated to lower gross sales by 1.0% within the third quarter and improve gross sales by 0.5% within the full yr, assuming the foreign money change charges in impact as of June 26, 2026) the extra parts that may be mirrored in any such GAAP measures (such because the affect of foreign money change charges on profitability, future acquisitions, divested product strains, discrete tax changes, impairments, beneficial properties and losses on investments and the end result of authorized proceedings) are tough to foretell and estimate and are sometimes depending on future occasions which may be unsure or exterior of our management. The affect of those further parts could possibly be materials to our outcomes computed in accordance with GAAP.

For the third quarter 2026, the Company anticipates that non-GAAP core income will improve within the 2.0% to three.0% vary year-over-year.

For full yr 2026, the Company expects non-GAAP core income will improve within the 3.0% to 4.0% vary year-over-year. The Company can be rising its full yr adjusted diluted web earnings per widespread share steerage to a variety of $8.45 to $8.60 versus earlier steerage of $8.35 to $8.55.

Conference Call and Webcast Information

Danaher will focus on its second quarter outcomes and monetary steerage for the third quarter and full yr 2026, together with as relevant key assumptions with respect thereto, throughout its investor convention name immediately beginning at 8:00 a.m. ET. The name and an accompanying slide presentation shall be webcast on the “Investors” part of Danaher’s web site, www.danaher.com, beneath the subheading “Events & Presentations.” A replay of the webcast shall be obtainable in the identical part of Danaher’s web site shortly after the conclusion of the presentation and can stay obtainable till the following quarterly earnings name.

The convention name will be accessed by dialing 833-419-0865, throughout the U.S. or +1 785-838-9333 exterior the U.S. a couple of minutes earlier than 8:00 a.m. ET and notifying the operator that you’re dialing in for Danaher’s earnings convention name (Conference ID: DHRQ226). A replay of the convention name shall be obtainable shortly after the conclusion of the decision and till August 4, 2026. You can entry the replay dial-in data on the “Investors” part of Danaher’s web site beneath the subheading “Events & Presentations.”

ABOUT DANAHER

Danaher is a number one world life sciences and diagnostics innovator, dedicated to accelerating the ability of science and expertise to enhance human well being. Through our related ecosystem of industry-leading companies, we work facet by facet with clients to unravel their most complicated scientific and medical challenges—serving to transfer improvements from discovery to supply sooner for sufferers who rely upon them.

Powered by the Danaher Business System, our superior science and expertise and confirmed capability to innovate assist allow sooner, extra correct diagnoses and scale back the time, value, and threat required to find, develop, and ship life-changing therapies. Through steady enchancment and operational excellence, our roughly 60,000 associates worldwide are centered on delivering lasting affect and enhancing high quality of life around the globe, whereas constructing a more healthy, extra sustainable tomorrow. Explore extra at www.danaher.com.

NON-GAAP MEASURES AND SUPPLEMENTAL MATERIALS

In addition to the monetary measures ready in accordance with GAAP, this earnings launch additionally incorporates non-GAAP monetary measures. Calculations of those measures, explanations of what these measures signify and the the reason why we consider these measures present helpful data to buyers, a reconciliation of those measures to probably the most instantly comparable GAAP measures, the place relevant, and different data relating to those non-GAAP measures are included within the supplemental reconciliation schedule hooked up.

In addition, this earnings launch, the slide presentation accompanying the associated earnings name, non-GAAP reconciliations and a notice containing particulars of historic and anticipated, future monetary efficiency have been posted to the “Investors” part of Danaher’s web site (www.danaher.com).

FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION

Statements on this launch that aren’t strictly historic, together with the statements concerning the Company’s anticipated monetary outcomes for the third quarter and full yr 2026, the Company’s expectations concerning development and market restoration, the Company’s positioning to create long-term shareholder worth, and every other statements concerning occasions or developments that we consider or anticipate will or could happen sooner or later are “forward-looking” statements throughout the that means of the federal securities legal guidelines. There are various necessary elements that might trigger precise outcomes, developments and enterprise selections to vary materially from these advised or indicated by such forward-looking statements and you shouldn’t place undue reliance on any such forward-looking statements. These elements embody, amongst different issues: the affect of the tariffs and associated actions applied by the U.S. and different nations, the affect of our debt obligations (together with debt we incurred to finance the acquisition of Masimo Corporation) on our operations and liquidity, deterioration of or instability within the world financial system, the markets we serve and the monetary markets, uncertainties with respect to the event, deployment, and use of synthetic intelligence in our enterprise and merchandise, the affect of world well being crises, uncertainties regarding nationwide legal guidelines or insurance policies, together with legal guidelines or insurance policies to guard or promote home pursuits and/or handle overseas competitors, our capability to efficiently determine and consummate applicable acquisitions and strategic investments, our capability to combine the companies we purchase and obtain the anticipated development, synergies and different advantages of such acquisitions, contingent liabilities and different dangers regarding acquisitions, investments, strategic relationships and divestitures (in every case, together with with respect to our acquisition of Masimo Corporation), together with tax-related and different contingent liabilities regarding previous and future IPOs, split-offs or spin-offs, contractions or development charges and cyclicality of markets we serve, competitors, our capability to develop and efficiently market new merchandise and applied sciences and broaden into new markets, the potential for improper conduct by our staff, brokers or enterprise companions, our compliance with relevant legal guidelines and rules (together with guidelines regarding off-label advertising and marketing and different rules regarding medical units and the well being care {industry}), the outcomes of our medical trials and perceptions thereof, our capability to successfully handle value reductions and different adjustments within the well being care {industry}, safety breaches or different disruptions of our data expertise methods or violations of knowledge privateness legal guidelines, dangers regarding potential impairment of goodwill and different intangible belongings, foreign money change charges, tax audits and adjustments in our tax fee and revenue tax liabilities, adjustments in tax legal guidelines relevant to multinational firms, litigation, regulatory proceedings and different contingent liabilities together with mental property and environmental, well being and security issues, the rights of the United States authorities with respect to our manufacturing capability in instances of nationwide emergency or with respect to mental property/manufacturing capability developed utilizing authorities funding, dangers regarding product, service or software program defects, product legal responsibility and remembers, dangers regarding our manufacturing operations, the affect of local weather change, authorized or regulatory measures to deal with local weather change and different sustainability subjects and our capability to deal with regulatory necessities or stakeholder expectations regarding local weather change and different sustainability subjects, dangers regarding fluctuations in the fee and availability of the provides we use (together with commodities) and labor we’d like for our operations, {our relationships} with and the efficiency of our channel companions, uncertainties regarding collaboration preparations with third-parties, the affect of deregulation on demand for our services and products, labor issues and our capability to recruit, retain and encourage proficient staff, U.S. and non-U.S. financial, political, geopolitical, authorized, compliance, social and enterprise elements (together with the affect of elections, regulatory and coverage adjustments or uncertainty, authorities shutdowns and army conflicts such because the battle within the Middle East), disruptions and different impacts regarding man-made and pure disasters, inflation and the affect of our By-law unique discussion board provisions. Additional data concerning the elements which will trigger precise outcomes to vary materially from these forward-looking statements is offered in our SEC filings, together with our 2025 Annual Report on Form 10-Ok and Quarterly Report on Form 10-Q for the second quarter of 2026. These forward-looking statements converse solely as of the date of this launch and besides to the extent required by relevant regulation, the Company doesn’t assume any obligation to replace or revise any forward-looking assertion, whether or not on account of new data, future occasions and developments or in any other case.

This press launch could embody descriptions of sure merchandise and/or units which have purposes submitted and pending for sure regulatory approvals, or can be found solely in sure markets.

This data is offered for reference solely. A whole copy of Danaher’s Form 10-Q monetary statements is offered on the Company’s web site (www.danaher.com).

Note: Beginning with the Company’s Quarterly Report on Form 10-Q for the second quarter of 2026, along with disclosing core gross sales development, the Company is disclosing a brand new non-GAAP measure, titled “Core sales growth excluding respiratory testing.” This new measure adjusts core gross sales to exclude revenues associated to the sale of respiratory testing merchandise within the Company’s molecular diagnostics enterprise within the Diagnostics phase. Demand for respiratory testing relies upon considerably on the severity ranges of influenza and influenza-like sickness in a given interval, and these severity ranges aren’t beneath administration’s management. As a consequence, presenting core gross sales on a foundation that mixes respiratory testing income with different Diagnostics enterprise revenues can obscure underlying development developments throughout the Diagnostics companies.  The Company believes that presenting this extra measure will complement core gross sales, improve buyers’ understanding of the historic and anticipated efficiency of the Diagnostics companies and Danaher as an entire, together with with respect to underlying development developments, and facilitate comparisons of period-to-period efficiency. In addition, starting with the Company’s Quarterly Report on Form 10-Q for the third quarter of 2026, the Company intends to exclude from the core gross sales measures the affect, if any, of tariff refunds (associated to tariff funds made in prior intervals) which might be returned, or anticipated to be returned, to clients. The Company believes this adjustment will assist buyers higher perceive underlying development developments within the Company’s enterprise that in any other case could also be obscured by the above-noted tariff-related impacts.

Pending SLMP LLC “StatLab” Acquisition

Earlier this month, Leica Biosystems, our anatomic pathology enterprise, introduced their intention to amass StatLab, a number one producer of merchandise throughout the core histology workflow, from specimen assortment by means of slide staining. The enterprise has >85% recurring income and is complementary to Leica Biosystems’ current oncology instrument portfolio.

Below is a few data on StatLab:

• StatLab generated ~$250M in income for the total yr 2025
• The Company expects StatLab to have +high-single digit core gross sales development over the long run
• The Company expects StatLab to be accretive to Adjusted diluted web earnings per widespread share (non-GAAP) within the 1st full yr of possession
• The Company expects to shut this acquisition by the top of 2026, topic to customary closing circumstances and regulatory approvals

Note: For the affect of respiratory testing, a optimistic quantity represents a year-over-year headwind to core gross sales development, and a unfavourable quantity represents a year-over-year tailwind to core gross sales development.

We outline free money move as working money flows, much less funds for additions to property, plant and tools (“capital expenditures”) plus the proceeds from gross sales of plant, property and tools (“capital disposals”).

Statement Regarding Non-GAAP Measures

Each of the non-GAAP measures set forth above needs to be thought of along with, and never as a substitute for or superior to, the comparable GAAP measure, and is probably not akin to equally titled measures reported by different firms. Management believes that these measures present helpful data to buyers by providing further methods of viewing Danaher Corporation’s (“Danaher” or the “Company”) outcomes that, when reconciled to the corresponding GAAP measure, assist our buyers:

• with respect to the profitability-related non-GAAP measures, perceive the long-term profitability developments of our enterprise and examine our profitability to prior and future intervals and to our friends;
• with respect to the non-GAAP measures associated to core gross sales, determine underlying development developments in our enterprise and examine our gross sales efficiency with prior and future intervals and to our friends; and
• with respect to free money move (the “FCF Measure”), perceive Danaher’s capability to generate money with out exterior financings, strengthen its stability sheet, spend money on its enterprise and develop its enterprise by means of acquisitions and different strategic alternatives (though a limitation of free money move is that it doesn’t have in mind the Company’s debt service necessities and different non-discretionary expenditures, and because of this the complete free money move quantity shouldn’t be essentially obtainable for discretionary expenditures).

Management makes use of the non-GAAP measures referenced above to measure the Company’s working and monetary efficiency, and makes use of core gross sales and non-GAAP measures much like Adjusted Diluted Net Earnings Per Common Share, Adjusted Operating Profit and the FCF Measure within the Company’s govt compensation program.

The objects excluded from the non-GAAP measures set forth above have been excluded for the next causes:

• With respect to the profitability-related non-GAAP measures:
• Amortization of Intangible Assets: We exclude the amortization of acquisition-related intangible belongings as a result of the quantity and timing of such expenses are considerably impacted by the timing, dimension, quantity and nature of the acquisitions we consummate. While we’ve got a historical past of serious acquisition exercise we don’t purchase companies on a predictable cycle, and the quantity of an acquisition’s buy value allotted to intangible belongings and the associated amortization time period are distinctive to every acquisition and may fluctuate considerably from acquisition to acquisition. Exclusion of this amortization expense facilitates extra constant comparisons of working outcomes over time between our newly acquired and long-held companies, and with each acquisitive and non-acquisitive peer firms. We consider nevertheless that it’s important for buyers to grasp that such intangible belongings contribute to gross sales era and that intangible asset amortization associated to previous acquisitions will recur in future intervals till such intangible belongings have been totally amortized.
• Restructuring Charges: We exclude prices incurred pursuant to discrete restructuring plans which might be basically totally different (by way of the scale, strategic nature and planning necessities, in addition to the inconsistent frequency, of such plans) from the continued productiveness enhancements that consequence from software of the Danaher Business System. Because these restructuring plans are incremental to the core actions that come up within the peculiar course of our enterprise and we consider aren’t indicative of Danaher’s ongoing working prices in a given interval, we exclude these prices to facilitate a extra constant comparability of working outcomes over time.
• Other Adjustments: With respect to the opposite objects excluded from the profitability-related non-GAAP measures, we exclude these things as a result of they’re of a nature and/or dimension that happen with inconsistent frequency, happen for causes which may be unrelated to Danaher’s business efficiency through the interval and/or we consider that such objects could obscure underlying enterprise developments and make comparisons of long-term efficiency tough. 
• With respect to core gross sales, (1) we exclude the affect of foreign money translation as a result of it’s not beneath administration’s management, is topic to volatility and may obscure underlying enterprise developments, and (2) we exclude the impact of acquisitions and divested product strains as a result of the timing, dimension, quantity and nature of such transactions can fluctuate considerably from period-to-period and between us and our friends, which we consider could obscure underlying enterprise developments and make comparisons of long-term efficiency tough. Please see “Sales Growth by Segment, Core Sales Growth (Decline) by Segment and Core Sales Growth Excluding Respiratory Testing” above for a proof on why we exclude respiratory testing revenues from the non-GAAP measure “Core sales excluding respiratory testing”. In addition, starting with the Company’s Quarterly Report on Form 10-Q within the third quarter of 2026, the Company intends to exclude from core gross sales the affect of tariff refunds associated to prior interval tariffs which might be returned, or anticipated to be returned, if any, to clients because the Company believes these quantities could obscure underlying enterprise developments. 
• With respect to the FCF Measure, we deduct funds for additions to property, plant and tools (web of the proceeds from capital disposals) to display the quantity of working money move for the interval that is still after accounting for the Company’s capital expenditure necessities.

SOURCE Danaher Corporation